| Literature DB >> 22083418 |
Hisaharu Oya1, Takuji Gotoda, Tetsu Kinjo, Haruhisa Suzuki, Shigetaka Yoshinaga, Hirokazu Taniguchi, Ryoji Kushima, Makoto Saka, Hitoshi Katai, Ichiro Oda.
Abstract
Currently in Japan, differentiated gastric submucosal invasive cancers <500 μm (SM1) with negative lymphovascular involvement are included in expanded pathological criteria for curative endoscopic treatment. This is based on a retrospective examination of surgical resection cases in which patients suitable for such expanded criteria were determined to have a negligible risk of lymph node metastasis. We performed endoscopic submucosal dissection on a 65-year-old male with early gastric cancer in April 2005, and pathology revealed a well-differentiated adenocarcinoma, 21 × 10 mm in size, SM1 invasion depth and negative lymphovascular invasion as well as tumor-free margins, so the case was diagnosed as a curative resection. This case, however, resulted in lymph node metastasis that was diagnosed by endoscopic ultrasonography with fine-needle aspiration biopsy in May 2009. Distal gastrectomy with D2 lymph node dissection was then performed, confirming lymph node metastasis from the original gastric cancer.Entities:
Mesh:
Year: 2011 PMID: 22083418 DOI: 10.1007/s10120-011-0111-8
Source DB: PubMed Journal: Gastric Cancer ISSN: 1436-3291 Impact factor: 7.370